Calidi Biotherapeutics Inc (CLDI)
0.242
+0.01
(+3.60%)
USD |
NYAM |
May 16, 16:00
0.2464
0.00 (0.00%)
After-Hours: 20:00
Calidi Biotherapeutics Total Return Price: 0.2464 for May 16, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 15, 2024 | 0.2336 |
| May 14, 2024 | 0.2258 |
| May 13, 2024 | 0.2222 |
| May 10, 2024 | 0.236 |
| May 09, 2024 | 0.232 |
| May 08, 2024 | 0.239 |
| May 07, 2024 | 0.2267 |
| May 06, 2024 | 0.21 |
| May 03, 2024 | 0.197 |
| May 02, 2024 | 0.201 |
| May 01, 2024 | 0.193 |
| April 30, 2024 | 0.195 |
| April 29, 2024 | 0.208 |
| April 26, 2024 | 0.1607 |
| April 25, 2024 | 0.16 |
| April 24, 2024 | 0.1579 |
| April 23, 2024 | 0.167 |
| April 22, 2024 | 0.156 |
| April 19, 2024 | 0.162 |
| April 18, 2024 | 0.16 |
| April 17, 2024 | 0.195 |
| April 16, 2024 | 0.2071 |
| April 15, 2024 | 0.60 |
| April 12, 2024 | 0.6948 |
| April 11, 2024 | 0.6396 |
| Date | Value |
|---|---|
| April 10, 2024 | 0.5872 |
| April 09, 2024 | 0.6171 |
| April 08, 2024 | 0.38 |
| April 05, 2024 | 0.3961 |
| April 04, 2024 | 0.4238 |
| April 03, 2024 | 0.49 |
| April 02, 2024 | 0.499 |
| April 01, 2024 | 0.553 |
| March 28, 2024 | 0.565 |
| March 27, 2024 | 0.5677 |
| March 26, 2024 | 0.57 |
| March 25, 2024 | 0.586 |
| March 22, 2024 | 0.58 |
| March 21, 2024 | 0.6012 |
| March 20, 2024 | 0.653 |
| March 19, 2024 | 0.6144 |
| March 18, 2024 | 0.60 |
| March 15, 2024 | 0.637 |
| March 14, 2024 | 0.609 |
| March 13, 2024 | 0.63 |
| March 12, 2024 | 0.673 |
| March 11, 2024 | 0.613 |
| March 08, 2024 | 0.631 |
| March 07, 2024 | 0.694 |
| March 06, 2024 | 0.6784 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.156
Minimum
Apr 22 2024
10.69
Maximum
Aug 16 2023
7.723
Average
9.90
Median
Apr 04 2022
Total Return Price Benchmarks
| Minerva Neurosciences Inc | 2.56 |
| Viking Therapeutics Inc | 69.16 |
| CytomX Therapeutics Inc | 2.00 |
| Genprex Inc | 2.35 |
| Janux Therapeutics Inc | 47.49 |